Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After …
Background—The optimal duration of dual antiplatelet therapy (DAPT) after implantation of
drug-eluting coronary stents remains undetermined. We aimed to test whether 6-month …
drug-eluting coronary stents remains undetermined. We aimed to test whether 6-month …
Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial
DJ Kereiakes, RW Yeh, JM Massaro… - Jama, 2015 - jamanetwork.com
Importance Despite antirestenotic efficacy of coronary drug-eluting stents (DES) compared
with bare metal stents (BMS), the relative risk of stent thrombosis and adverse …
with bare metal stents (BMS), the relative risk of stent thrombosis and adverse …
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a …
Background Current guidelines recommend dual antiplatelet therapy (DAPT) of aspirin plus
a P2Y12 inhibitor for at least 12 months after implantation of drug-eluting stents (DES) in …
a P2Y12 inhibitor for at least 12 months after implantation of drug-eluting stents (DES) in …
P2Y12 Inhibitor or Aspirin Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Network Meta-Analysis
Background It is still unknown which antiplatelet monotherapy should be continued after a
period of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary …
period of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary …
Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome
C Varenhorst, K Jensevik, T Jernberg… - European heart …, 2014 - academic.oup.com
Aims Dual antiplatelet treatment (DAPT) is a cornerstone in the treatment of acute coronary
syndrome (ACS) but the optimal treatment duration is unclear. We aimed to evaluate the …
syndrome (ACS) but the optimal treatment duration is unclear. We aimed to evaluate the …
Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials
Background: The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent
(DES) implantation is unclear, and its risks and benefits may vary according to DES …
(DES) implantation is unclear, and its risks and benefits may vary according to DES …
Dual antiplatelet therapy in coronary artery disease: from the past to the future prospective
A Mangieri, F Gallo, A Sticchi, AA Khokhar… - Cardiovascular …, 2020 - Springer
Antiplatelet therapy, the cornerstone of post coronary stenting antithrombotic therapy,
reduces the rate of hard clinical endpoints in patients treated both conservatively and …
reduces the rate of hard clinical endpoints in patients treated both conservatively and …
[PDF][PDF] Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent …
G De Luca, SA Damen, C Camaro, E Benit… - …, 2019 - academia.edu
Aims: The optimal duration of DAPT in ACS patients treated with DES is still unclear.
Therefore, the aim of the current study was to investigate a short versus a standard 12-month …
Therefore, the aim of the current study was to investigate a short versus a standard 12-month …
Meta-analysis of randomized clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stents
G El-Hayek, F Messerli, S Bangalore, MK Hong… - The American journal of …, 2014 - Elsevier
Current guidelines recommend 12 months of dual antiplatelet therapy (DAPT) after drug-
eluting stent (DES) implantation in the absence of increased bleeding risk. Studies have …
eluting stent (DES) implantation in the absence of increased bleeding risk. Studies have …